Mary Miller - 14 Nov 2024 Form 4 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Issuer symbol
ACRV
Transactions as of
14 Nov 2024
Net transactions value
-$1,457
Form type
4
Filing time
18 Nov 2024, 16:31:47 UTC
Previous filing
21 Oct 2024
Next filing
22 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRV Common Stock Tax liability $1,457 -184 -0.48% $7.92 37,941 14 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.